Showing results (1081-1090 of 1,252) with videos related to

Sort By:
Pageof 126
Pharmaceuticals (Basel, Switzerland)|April 3, 2023
The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of <i>Plasmodium falciparum</i> Viability after Antimalarial Treatment In VitroAnnabelle Walz, Maëlle Duffey, Ghaith Aljayyoussi, et al.
Infection Control and Hospital Epidemiology|October 16, 2004
Prevalence of nosocomial infections in Swiss children's hospitalsKathrin Mühlemann, Christine Franzini, Christoph Aebi, et al.
Therapeutic Drug Monitoring|November 15, 2017
Efavirenz Therapeutic Range in HIV-1 Treatment-Naive ParticipantsCindy J Bednasz, Charles S Venuto, Qing Ma, et al.
Plos One|November 15, 2014
HIV cure strategies: how good must they be to improve on current antiretroviral therapy?Paul E Sax, Alexis Sypek, Bethany K Berkowitz, et al.
BMJ Quality & Safety|June 29, 2018
Implementing infection prevention practices across European hospitals: an in-depth qualitative assessmentLauren Clack, Walter Zingg, Sanjay Saint, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2019
Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202Cindy J Bednasz, Charles S Venuto, Qing Ma, et al.
Malaria Journal|November 19, 2013
Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparumClaire Le Manach, Christian Scheurer, Sibylle Sax, et al.
Journal of the American Chemical Society|November 8, 2012
The role of order-disorder transitions in the quest for molecular multiferroics: structural and magnetic neutron studies of a mixed valence iron(II)-iron(III) formate frameworkLaura Cañadillas-Delgado, Oscar Fabelo, J Alberto Rodríguez-Velamazán, et al.
Pageof 126